Cargando…

Fast Tacrolimus Metabolism Does Not Promote Post-Transplant Diabetes Mellitus after Kidney Transplantation

Post-transplant diabetes mellitus (PTDM) after kidney transplantation induced by tacrolimus is an important issue. Fast tacrolimus metabolism, which can be estimated by concentration-to-dose (C/D) ratio, is associated with increased nephrotoxicity and unfavorable outcomes after kidney transplantatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jehn, Ulrich, Wiedmer, Nathalie, Boeckel, Göran Ramin, Pavenstädt, Hermann, Thölking, Gerold, Reuter, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408810/ https://www.ncbi.nlm.nih.gov/pubmed/36012395 http://dx.doi.org/10.3390/ijms23169131

Ejemplares similares

The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
por: Thölking, Gerold, et al.
Publicado: (2021)

Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantation
por: Thölking, Gerold, et al.
Publicado: (2021)

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
por: Thölking, Gerold, et al.
Publicado: (2020)

Clinical features of BK-polyomavirus and cytomegalovirus co-infection after kidney transplantation
por: Jehn, Ulrich, et al.
Publicado: (2020)

Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation
por: Jehn, Ulrich, et al.
Publicado: (2020)

The Tacrolimus Metabolism Rate Influences Renal Function after Kidney Transplantation
por: Thölking, Gerold, et al.
Publicado: (2014)

Antihypertensive Treatment in Kidney Transplant Recipients—A Current Single Center Experience
por: Jehn, Ulrich, et al.
Publicado: (2020)

Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation
por: Thölking, Gerold, et al.
Publicado: (2016)

Improved Kidney Allograft Function after Early Conversion of Fast IR-Tac Metabolizers to LCP-Tac
por: Thölking, Gerold, et al.
Publicado: (2022)

Commentary: The Clinical Impact of the C(0)/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
por: Thölking, Gerold, et al.
Publicado: (2021)

Influence of tacrolimus metabolism rate on renal function after solid organ transplantation
por: Thölking, Gerold, et al.
Publicado: (2017)

The Influence of Parathyroidectomy on Osteoporotic Fractures in Kidney Transplant Recipients: Results from a Retrospective Single-Center Trial
por: Jehn, Ulrich, et al.
Publicado: (2022)

Is there a "weekend effect" in kidney transplantation?
por: Schütte-Nütgen, Katharina, et al.
Publicado: (2017)

Novel Therapeutic Strategies for Dyslipidemia: First Report of Inclisiran Therapy in a Kidney Transplanted Patient
por: Ueberdiek, Lars, et al.
Publicado: (2023)

A Low Tacrolimus Concentration/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity
por: Thölking, Gerold, et al.
Publicado: (2019)

Corrigendum: Novel Therapeutic Strategies for Dyslipidemia: First Report of Inclisiran Therapy in a Kidney Transplanted Patient
por: Ueberdiek, Lars, et al.
Publicado: (2023)

Expanding the donor pool in kidney transplantation: Should organs with acute kidney injury be accepted?—A retrospective study
por: Schütte-Nütgen, Katharina, et al.
Publicado: (2019)

First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
por: Jehn, Ulrich, et al.
Publicado: (2022)

Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
por: Jehn, Ulrich, et al.
Publicado: (2021)

Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation
por: Schütte-Nütgen, Katharina, et al.
Publicado: (2019)

Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation
por: Thölking, Gerold, et al.
Publicado: (2015)

Correction: Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation. J. Clin. Med. 2019, 8, 587
por: Schütte-Nütgen, Katharina, et al.
Publicado: (2019)

Conversion from Standard-Release Tacrolimus to MeltDose(®) Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
por: von Einsiedel, Johannes, et al.
Publicado: (2020)

Assessment of Hemostasis after Plasma Exchange Using Rotational Thrombelastometry (ROTEM)
por: Thölking, Gerold, et al.
Publicado: (2015)

Male kidney allograft recipients at risk for urinary tract infection?
por: Thölking, Gerold, et al.
Publicado: (2017)

Post-Transplant Diabetes Mellitus After Kidney Transplant in Hispanics and Caucasians Treated with Tacrolimus-Based Immunosuppression
por: Baron, Pedro W., et al.
Publicado: (2017)

The Tacrolimus Concentration/Dose Ratio Does Not Predict Early Complications After Kidney Transplantation
por: von Samson-Himmelstjerna, Friedrich Alexander, et al.
Publicado: (2023)

Post-transplant Diabetes Mellitus in Kidney Transplant Recipients in Sudan: A Comparison Between Tacrolimus and Cyclosporine-Based Immunosuppression
por: Yousif, Elamein, et al.
Publicado: (2022)

Prognostic Value of Growth Differentiation Factor 15 in Kidney Donors and Recipients
por: Jehn, Ulrich, et al.
Publicado: (2020)

The Effect of Proton Pump Inhibitor Use on Renal Function in Kidney Transplanted Patients
por: Flothow, Dominik J. G., et al.
Publicado: (2020)

Belatacept as a Treatment Option in Patients with Severe BK Polyomavirus Infection and High Immunological Risk—Walking a Tightrope between Viral Control and Prevention of Rejection
por: Jehn, Ulrich, et al.
Publicado: (2022)

iPTH is not a significant factor influencing the tacrolimus C/D ratio
por: Westphal, Florian, et al.
Publicado: (2022)

Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
por: Lee, John R., et al.
Publicado: (2015)

Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
por: Yu, Meng, et al.
Publicado: (2018)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Phenotypic and Genotypic Characterization of Escherichia coli Causing Urinary Tract Infections in Kidney-Transplanted Patients
por: Abo Basha, Jonas, et al.
Publicado: (2019)

Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
por: Cheng, Fang, et al.
Publicado: (2021)

Circulating Endothelial Progenitor Cells in Kidney Transplant Patients
por: Di Marco, Giovana S., et al.
Publicado: (2011)

A Comparison of Different Algorithms for the Assessment of Cardiovascular Risk in Patients at Waiting List for Kidney Transplantation
por: Reuter, Stefan, et al.
Publicado: (2016)

Tacrolimus Therapeutic Drug Monitoring in Kidney Transplant Patients Before and After Pharmacist Post-transplant Consults
por: Massoglia, Gabriella, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h9it8uce4g2ctarm0uaqf8ec1b